A Scottish clinic developing treatments for neurological conditions such as Alzheimer's and dementia has named a new chief executive as it prepares to open its second research facility.
Fiona Wood joined NeuroClin earlier this year from Clyde Munro Dental Group, where she was chief operating officer for six years. Her appointment comes as NeuroClin prepares for a period of "transformational growth", with a new facility in the north-west of England expected to open in the third quarter of this year.
Launched in 1999 as the Glasgow Memory Clinic, the business changed its name in 2022 when it moved to its current headquarters at Eurocentral in Lanarkshire. The facility is home to a number of national and international clinical studies seeking to find better treatments for memory impairment, depression, and other neurological diseases.
READ MORE: Advisory firm N4 Partners raises investment in ‘pioneering’ medical research business
“I’m excited to embark on this new chapter at NeuroClin," Ms Wood said.
"It’s great to announce our plans for a new site in England and my focus will be to work with the experienced team to further execute our growth and expansion strategy, unlocking further opportunities within the field of clinical research and continue to cement NeuroClin’s reputation as one of the world’s leading neurological research centres.”
In January NeuroClin closed a seven-figure investment round with further backing from its major shareholder, Glasgow-based N4 Partners, along with Foresight Group and Fullbrook Thorpe Investments. NeuroClin has been chaired since 2022 by global pharma executive Jeff Thomis.
READ MORE: N4 signs up Merrylees to head new investment fund
“It has been very encouraging to see the progress NeuroClin has made in continuing to build on its global reputation and further diversify the research base," Mr Thomis said. "A strong platform has been developed and, under Fiona’s leadership, we look ahead to further expansion.”
N4 was set up in 2020 by four former employees of Clyde Blowers Capital. It manages funds on behalf of institutional investors from Europe and the US, with a focus on the industrial, healthcare, technology, defence and energy sectors.
Why are you making commenting on The Herald only available to subscribers?
It should have been a safe space for informed debate, somewhere for readers to discuss issues around the biggest stories of the day, but all too often the below the line comments on most websites have become bogged down by off-topic discussions and abuse.
heraldscotland.com is tackling this problem by allowing only subscribers to comment.
We are doing this to improve the experience for our loyal readers and we believe it will reduce the ability of trolls and troublemakers, who occasionally find their way onto our site, to abuse our journalists and readers. We also hope it will help the comments section fulfil its promise as a part of Scotland's conversation with itself.
We are lucky at The Herald. We are read by an informed, educated readership who can add their knowledge and insights to our stories.
That is invaluable.
We are making the subscriber-only change to support our valued readers, who tell us they don't want the site cluttered up with irrelevant comments, untruths and abuse.
In the past, the journalist’s job was to collect and distribute information to the audience. Technology means that readers can shape a discussion. We look forward to hearing from you on heraldscotland.com
Comments & Moderation
Readers’ comments: You are personally liable for the content of any comments you upload to this website, so please act responsibly. We do not pre-moderate or monitor readers’ comments appearing on our websites, but we do post-moderate in response to complaints we receive or otherwise when a potential problem comes to our attention. You can make a complaint by using the ‘report this post’ link . We may then apply our discretion under the user terms to amend or delete comments.
Post moderation is undertaken full-time 9am-6pm on weekdays, and on a part-time basis outwith those hours.
Read the rules here